| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8726942 | Gastroenterology | 2018 | 59 Pages |
Abstract
miRNA21 appears to mediate resistance of CCA cells to HSP90 inhibitors by reducing levels of DNAJB5. HSP90 inhibitors might be developed for the treatment of CCA and miRNA21 might be a marker of sensitivity to these agents.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Andrea Lampis, Pietro Carotenuto, Georgios Vlachogiannis, Luciano Cascione, Somaieh Hedayat, Rosemary Burke, Paul Clarke, Else Bosma, Michele Simbolo, Aldo Scarpa, Sijia Yu, Rebecca Cole, Elizabeth Smyth, Javier Fernández Mateos, Ruwaida Begum,